A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Oral Doses of MYK-461 in Healthy Volunteers
Single Ascending Dose Study of MYK-461 in Healthy Volunteers
Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461
A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491
† Study has passed its completion date and status has not been verified in more than two years.